Answers are grounded in this paper and cite their sources.
Background: We analyzed the pharmacokinetic-pharmacodynamic relationship of vancomycin to determine the drug exposure parameters that correlate with the efficacy and nephrotoxicity of vancomycin in patients with methicillin-resistant Staphylococcus aureus pneumonia and evaluated the need to use peak concentration in therapeutic drug monitoring (TDM). Methods: Serum drug concentrations of 31 hospitalized patients treated with vancomycin for methicillin-resistant S. aureus pneumonia were collected. Results: Significant differences in trough concentration (Cmin)/minimum inhibitory concentration (MIC) and area under the serum concentration-time curve (AUC₀–₂₄)/MIC were observed between the response and non-response groups. Significant differences in Cmin and AUC₀–₂₄ were observed between the nephrotoxicity and non-nephrotoxicity groups. Receiver operating characteristic curves revealed high predictive values of Cmin/MIC and AUC₀–₂₄/MIC for efficacy and of Cmin and AUC₀–₂₄ for safety of vancomycin. Conclusions: These results suggest little need to use peak concentration in vancomycin TDM because Cmin/MIC and Cmin are sufficient to predict the efficacy and safety of vancomycin.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: